Day One Welcome
Session 1.1
Upstream TAVR Has Arrived, Should Guidelines Follow?
Chair: Nicolas Van Mieghem, Rotterdam, NL and Ole De Backer, Copenhagen, DK
Panel: Anita Asgar, Chicago, US; Sabine Bleiziffer, Bad Oeynhausen, DE; Thomas Modine, Bordeaux, FR; Giuseppe Tarantini, Padua, IT
Moderate AS - What’s Next After TAVR UNLOAD – Nicolas Van Mieghem
Asymptomatic Severe AS – A Home Run – Anita Asgar
Pure Aortic Regurgitation – A Legitimate TAVR Target? – Thomas Modine
Session 1.2
Live Cases
Chair: Ole De Backer, Copenhagen, DK
Panel: Anita Asgar, Chicago, US; Sabine Bleiziffer, Bad Oeynhausen, DE; Thomas Modine, Bordeaux, FR; Giuseppe Tarantini, Padua, IT
Pure Aortic Regurgitation Case – Nicolas Van Mieghem, Erasmus MC, Rotterdam, NL
TAVR-in-TAVR Case – Holger Thiele and Mohamed Abdel-Wahab, Leipzig Heart Center, Leipzig, DE
TAVI Index Procedure: The Value of Valve Optimisation on Long-term Outcomes and Lifetime Management
Symposium
Chair: Rui Teles, Carnaxide, PT
Panel: James Cockburn, Brighton, UK; Birgid Gonska, Bad Nauheim, DE; Vlasis Ninios, Thessaloniki, GR
Case Operator: Won-Keun Kim, University of Giessen & Marburg, Giessen, DE
Welcome and Introduction – Rui Teles, Carnaxide, PT
TAVI Procedure Optimisation: Lessons From the ACURATE IDE Study – James Cockburn, Brighton, UK
Enhancing TAVI Outcomes: Precise Valve Placement and Implantation – Birgid Gonska, Bad Nauheim, DE
Implications of Index Procedure Outcomes on Lifetime Patient Management – Vlasis Ninios, Thessaloniki, GR
Case in Focus: TAVI for Larger Annuli Patients – Won-Keun Kim, Giessen, DE
Panel Discussion and Q&A – All
This symposium is supported by an unrestricted educational grant from Boston Scientific.
*TAVI Index Procedure: The Value of Valve Optimisation on Long-term Outcomes and Lifetime Management has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 CME point, equating to 1 hour of learning. Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.
Session 1.3
Atrioventricular Valves
Chair: Azeem Latib, New York, US
Panel: Anita Asgar, Chicago, US; Adam Greenbaum, Atlanta, US; David Hildick-Smith, Brighton, UK; Philipp Lurz, Mainz, DE; Thomas Modine, Bordeaux, FR
A Plea for Upstream Secondary MR Treatment – Philipp Lurz
The Importance of Complete Elimination of TR – Adam Greenbaum
How Strongly Do We Need to Recommend Transcatheter LAA Closure – David Hildick-Smith
Session 1.4
Live Cases
Chair: Azeem Latib, New York, US
Panel: Anita Asgar, Chicago, US; Adam Greenbaum, Atlanta, US; David Hildick-Smith, Brighton, UK
TTVR Case – Philipp Lurz, University Medical Center Mainz, Mainz, DE
TTVR Case – Thomas Modine, Bordeaux University Hospital, Bordeaux, FR
Day One Close
Day Two Welcome
Session 2.1
Drug Coated Balloons
Chair: Margaret McEntegart, New York, US
Panel: Joost Daemen, Rotterdam, NL; Roxana Mehran, New York, US; Valeria Paradies, Rotterdam, NL; Giuseppe Tarantini, Padua, IT
Overview of the DCB Market / What Is New in Coronary Devices – Margaret McEntegart
The Undisputed Indications for DCB – Giuseppe Tarantini
How to Interpret a Good DCB Result With Invasive Imaging – Joost Daemen
Session 2.2
Live Cases
Chair: Margaret McEntegart, New York, US
Panel: Joost Daemen, Rotterdam, NL; Roxana Mehran, New York, US; Valeria Paradies, Rotterdam, NL; Giuseppe Tarantini, Padua, IT
Proximal LAD Imaging Guided – Holger Thiele and Mohamed Abdel-Wahab, Leipzig Heart Center, Leipzig, DE
LM Bifurcation DCB Case – David Hildick-Smith, Royal Sussex County Hospital, Brighton, UK
Session 2.3
Calcium Modification Revisited
Chair: Ajay Kirtane, New York, US
Panel: Azeem Latib, New York, US; Margaret McEntegart, New York, US; Valeria Paradies, Rotterdam, NL; Holger Thiele, Leipzig, DE
Latest Science on Atherectomy – Ajay Kirtane
Updates on Coronary Lithotripsy – Azeem Latib
Use More Invasive Imaging Guidance – Valeria Paradies
Session 2.4
Live Cases
Chair: Ajay Kirtane, New York, US
Panel: Azeem Latib, New York, US; Margaret McEntegart, New York, US; Valeria Paradies, Rotterdam, NL; Holger Thiele, Leipzig, DE
-
Atherectomy Case – Joost Daemen and Nicolas Van Mieghem, Erasmus MC, Rotterdam, NL
-
Lithotripsy Case – George Dangas and Annapoorna Kini, Mount Sinai, New York, US
Day Two Close
Day Three Welcome
Session 3.1
Keynote & Debate
Chair: Ajay Kirtane, New York, US
Panel: Roxana Mehran, New York, US; Holger Thiele, Leipzig, DE; Nicolas Van Mieghem, Rotterdam, NL
Keynote: Mike Gibson, Boston, US
Iterative AI – Mike Gibson
ACC Highlights – Roxana Mehran
Session 3.2
Live Cases
Chair: Ajay Kirtane, New York, US
Panel: Mohamed Abdel-Wahab, Leipzig, DE; Philipp Lurz, Mainz, DE; Roxana Mehran, New York, US; Holger Thiele, Leipzig, DE
TAVR in Low-Risk Patients Using an Intra-annular Device and a Dedicated Physiology Wire – Nicolas Van Mieghem and Rutger-jan Nuis, Erasmus MC, Rotterdam, NL
LAA Case – David Hildick-Smith, Royal Sussex County Hospital, Brighton, UK
Session 3.3
Controversies
Chair: Nicolas Van Mieghem, Rotterdam, NL
Panel: Joost Daemen, Rotterdam, NL; Michaela Hell, Mainz, DE; Ajay Kirtane, New York, US; Holger Thiele, Leipzig, DE
Is Photon Counting CT a Game Changer? – Michaela Hell
Pulmonary Thrombectomy Deserves a Strong Recommendation in the Guidelines – Holger Thiele
How Valid Is Quality of Life as a Major Study Endpoint? – Joost Daemen
Day Three Close
Day Four Welcome
Session 4.1
Renal Denervation – Time for Action
Chair: Ajay Kirtane, New York, US
Panel: Jeremy Bock, Arlington, US; Naomi Fisher, Boston, US; Antonio Gutierrez, Durham, US; Matheen Khuddus, Gainesville, US; Eric Secemsky, Boston, US; Raven Voora, Chapel Hill, US
Which Patients Benefit From RDN – Naomi Fisher
How to Set Up a RDN Programme in 2025 – Jeremy Bock
Case Presentation – Eric Secemsky
Case Presentation – Antonio Gutierrez
Session 4.2
DCBs in Contemporary Practice
Chair: Ajay Kirtane, New York, US
Panel: Suhail Dohad, Los Angeles, US; Kathleen Kearney, Seattle, US; Azeem Latib, New York, US; Margaret McEntegart, New York, US
What Are DCBs and Why and How Do I Use Them? – Azeem Latib
Case Presentation – Kathleen Kearney
Session 4.3
Approaching Calcified Lesions in 2025
Chair: Ajay Kirtane, New York, US
Panel: Suhail Dohad, Los Angeles, US; Kathleen Kearney, Seattle, US; Margaret McEntegart , New York, US
What’s Our Strategy? – Margaret McEntegart
What Role Does Imaging Play? – Suhail Dohad
Session 4.4
Should Acute PE Intervention Be Performed Routinely by ICs?
Chair: Jay Giri, Philadelphia, US
Panel: Jay Mathews, Bradenton, US; Sahil Parikh, New York, US; Sonal Pruthi, New York, US; Sanjum Sethi, New York, US
Should Acute PE intervention be performed routinely by ICs? – Sahil Parikh
How to Set Up an Acute PE Program – Jay Mathews
Session 4.5
Aortic Session
Chair: Azeem Latib, New York, US
Panel: Sebastian Iturra, Minneapolis, US; Amar Krishnaswamy, Cleveland, US, Susheel Kodali, New York, US; Andrea Scotti, New York, US; Nicolas Van Mieghem, Rotterdam, NL
TAVR in Younger Patients – Where Do We Stand? – Andrea Scotti
Case-In-A-Box With Discussion – TAVR in TAVR / TAVR Explant – Sebastian Iturra
The Future – Amar Krishnaswamy
Session 4.6
Mitral Session
Chair: Azeem Latib, New York, US
Panel: Anita Asgar Chicago, US; Manaf Assafin, New York, US; Neil Fam, Toronto, CA; Susheel Kodali, New York, US; Scott Lim, Charlottesville, US; Nicolas Van Mieghem, Rotterdam, NL
Contemporary Mitral Valve Intervention in 2025 – Anita Asgar
Case-In-A-Box With Discussion – Emerging Technology – Manaf Assafin
The Future – Scott Lim
Session 4.7
Tricuspid Session
Chair: Azeem Latib, New York, US
Panel: Anita Asgar Chicago, US; Neil Fam, Toronto, CA; Edwin Ho, New York, US; Susheel Kodali, New York, US; Nicolas Van Mieghem, Rotterdam, NL
Contemporary Tricuspid Valve Intervention in 2025 – Edwin Ho
Case-in-a-box With Discussion – Emerging Technology – Neil Fam
The Future – Susheel Kodali
Management of Degenerative MR With TEER: An Evidence-based Guide
Symposium
Chair: Tarun Chakravarty, Los Angeles, US
Panel: Firas Zahr, Portland, US; Tom Cahill, Oxford, UK
Welcome and Introduction
Transcatheter Repair: Selection in Degenerative MR
Making Evidence-based Decisions in TEER – Insights From Recent Clinical Data
Technical Considerations for TEER in DMR Patients
Panel Discussion and Q&A
This symposium is supported by an unrestricted educational grant from Edwards Lifesciences.
*Management of Degenerative MR With TEER: An Evidence-based Guide’s programme will be submitted for CME accreditation.
Nicolas Van Mieghem
Course Director
Thoraxcenter, Erasmus MC, Rotterdam, NL
more info
David Hildick-Smith
Course co-director
Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton, UK
more info
Roxana Mehran
Course co-director
The Mount Sinai Hospital, New York, US
more info
Holger Thiele
Course co-director
Leipzig Heart Hospital, Leipzig, DE
more info
Ajay Kirtane
Course co-director
Columbia University Medical Center and New York-Presbyterian Hospital, New York, US
more info
Azeem Latib
Course co-director
Montefiore Medical Center, New York, US
more info
Mohamed Abdel-Wahab
Leipzig Heart Center, Leipzig, DE
Anita Asgar
Northwestern University, Chicago, US
Sabine Bleiziffer
Heart and Diabetes Center NRW, Bad Oeynhausen, DE
James Cockburn
Royal Sussex County Hospital, Brighton, UK
Joost Daemen
Thoraxcenter, Erasmus MC, Rotterdam, NL
Ole De Backer
Rigshospitalet, Copenhagen, DK
Michael Gibson
Harvard Medical School, Boston, US
Birgid Gonska
Kerckhoff Heart Center, Bad Nauheim, DE
Adam Greenbaum
Emory University, Atlanta, US
Michaela Hell
University Medical Center Mainz, Mainz, DE
Won-Keun Kim
University of Giessen & Marburg, Giessen, DE
Philipp Lurz
University Medical Center Mainz, Mainz, DE
Margaret McEntegart
Columbia University Medical Center and New York-Presbyterian Hospital, New York, US
Thomas Modine
Bordeaux University Hospital, Bordeaux, FR
Vlasis Ninios
European Interbalkan Medical Center, Thessaloniki, GR
Valeria Paradies
Maasstad Hospital, Rotterdam, NL
Giuseppe Tarantini
University Hospital of Padova, Padova, IT
Rui Teles
Hospital de Santa Cruz, Carnaxide, PT
